| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Eli Lilly & Co (LLY) has 20 insiders with recent SEC Form 4 filings, including 0 buys and 93 sells. LLY is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 92.18M | $101.27B | - | |
| CEO | 515.2K | $565.95M | - | |
| VP | 137.5K | $151.03M | - | |
| Dir | 75.1K | $82.50M | - | |
| Dir | 55.5K | $60.94M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | Lilly Endowment Inc | - | Sell | 40,432 | $951.56 | $38,473,442.10 | - | +8.4% | - | |
| Nov 4, 2025 | Lilly Endowment Inc | - | Sell | 526 | $910.72 | $479,038.19 | - | +15.1% | - | |
| Nov 3, 2025 | Lilly Endowment Inc | - | Sell | 300,000 | $888.83 | $266,648,920.78 | - | +16.5% | - | |
| Oct 31, 2025 | Lilly Endowment Inc | - | Sell | 301,342 | $863.35 | $260,165,030.94 | - | +18.7% | - | |
| Oct 10, 2025 | Lilly Endowment Inc | - | Sell | 3,658 | $863.24 | $3,157,722.23 | - | +30.2% | - | |
| Oct 9, 2025 | Lilly Endowment Inc | - | Sell | 10,602 | $852.49 | $9,038,055.41 | - | +29.5% | - | |
| Oct 8, 2025 | Lilly Endowment Inc | - | Sell | 101,420 | $850.27 | $86,234,873.84 | - | +25.8% | - | |
| Oct 7, 2025 | Lilly Endowment Inc | - | Sell | 26,795 | $848.01 | $22,722,401.16 | - | +23.5% | - | |
| Oct 6, 2025 | Lilly Endowment Inc | - | Sell | 161,183 | $850.22 | $137,041,656.51 | - | +23.2% | - | |
| Oct 3, 2025 | Lilly Endowment Inc | - | Sell | 192,404 | $837.93 | $161,220,401.35 | - | +28.6% | - |